Breathing Training for Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether adding a special breathing exercise to cognitive training can slow memory and thinking problems in older adults with mild cognitive impairment (MCI). Participants will try different combinations of training and breathing exercises, including Resonance Frequency Breathing (RFB), to determine which is most effective. Individuals diagnosed with mild memory issues related to Alzheimer's and who maintain a stable medication routine might be suitable for this study. The goal is to assess if these exercises can improve brain function and delay dementia symptoms. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group.
Will I have to stop taking my current medications?
The trial requires that if you are on Alzheimer's disease medication, antidepressants, anxiolytics, or medications for vascular risk or diseases, your dose should be stable for 3 months before joining. You don't need to stop these medications, but you should not change the dose during this period.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that a breathing technique called resonance frequency breathing (RFB) is generally safe. Studies suggest that slow breathing methods like RFB can improve heart rate variability, indicating better heart health. Proper instruction is important to ensure safety.
For the cognitive training part, known as VSOP, research indicates it significantly improves processing speed and attention in older adults. This training is often used for individuals with mild cognitive impairment (MCI) and is considered safe.
Participants in studies have well-tolerated both RFB and VSOP. There have been no significant reports of serious side effects for either treatment, making them promising options for those considering joining a trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the breathing training for cognitive impairment because it offers a novel, non-invasive approach that could improve cognitive function. Unlike standard care options like medications, which often target neurotransmitters, this method utilizes Resonance Frequency Breathing (RFB) combined with Visual and Sensory Oriented Processing (VSOP) to potentially enhance brain health through focused breathing and visual exercises. This technique is unique as it harnesses the body's natural rhythms and may promote neuroplasticity, providing a fresh angle on tackling cognitive decline. Additionally, the use of app-guided exercises makes it accessible and easy to incorporate into daily routines, which could improve adherence and outcomes.
What evidence suggests that this trial's treatments could be effective for mild cognitive impairment?
Research has shown that combining a special breathing technique called resonance frequency breathing (RFB) with brain exercises can improve thinking skills in older adults with mild memory problems. In this trial, participants in the RFB+VSOP (MCI) arm will engage in this combination of treatments. Studies have found that deep, slow breathing like RFB enhances the effectiveness of brain exercises. Additionally, activities that connect the mind and body, including RFB, have been shown to help older adults with mild memory issues improve their thinking and daily activities. For the VSOP (Vision-based Speed of Processing) training, research has demonstrated that it helps people with mild memory problems think faster and pay better attention. Together, these treatments may improve brain function and slow memory decline. Participants in the IR+VSOP (MCI) arm will receive a control strategy using Guided Imagery Relaxation (IR) instead of RFB, while the IR only (MCI) arm will focus solely on IR.12367
Are You a Good Fit for This Trial?
This trial is for older adults aged 60-89 with mild cognitive impairment due to Alzheimer's, who score within a specific range on cognitive assessments and can handle daily activities. They must be stable on certain medications if taken, speak English, have good vision and hearing for app use, and not have major cardiovascular diseases or other disqualifying conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive an 8-week combined intervention of RFB+VSOP or control interventions with periodical booster training sessions
Follow-up
Participants are monitored for long-term effects on ANS flexibility and cognitive function
Booster Sessions
Periodical booster training sessions to reinforce treatment effects
What Are the Treatments Tested in This Trial?
Interventions
- IR
- RFB
- VSOP
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator
Stanford University
Collaborator